DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

NCT06275958 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

587

Enrollment

OTHER

Sponsor class

Conditions

Older Patients
Colorectal Cancer
Metastatic Cancer
Candidates for Palliative Chemotherapy

Interventions

DRUG: Doublet Chemotherapy, Standard Dose (100%)
DRUG: Doublet Chemotherapy, Dose-reduced (75%)
DRUG: Monotherapy, Standard Dose (100%)
DRUG: Monotherapy, Dose-reduced (75%)

Sponsor

Leiden University Medical Center

Collaborators

[object Object]